ICMR- National Institute of Malaria Research (NIMR), New Delhi, India.
ICMR- National Institute of Cancer Prevention and Research (NICPR), Noida, UP, India.
BMJ Open. 2024 Jul 4;14(7):e081856. doi: 10.1136/bmjopen-2023-081856.
India's contribution to the malaria burden was highest in South-East Asia Region in 2021, accounting for 79% of the estimated malaria cases and 83% of malaria-related deaths. Intensified Malaria Control Programme supported by Global Funds to Fight against AIDS, Tuberculosis and Malaria has deployed crucial interventions to reduce the overall burden of malaria in India. Evaluation of utilisation of malaria elimination interventions by the community and assessment of the healthcare system is underway in eleven high malaria endemic states in India. Health system preparedness for malaria elimination, logistics, and supply chain management of diagnostic kits and anti-malarial drugs in addition to the knowledge, attitude and practice of the healthcare workers is also being assessed.
The study is being undertaken in 11 malaria endemic states with a variable annual parasite incidence of malaria. In total, 47 districts (administrative unit of malaria control operations) covering 37 976 households are to be interviewed and assessed. We present here the protocol following which the study is being undertaken at the behest and approval of Ministry of Health and Family Welfare in India.
No patients were involved in the study. Study findings will be shared with Institutional ethics board of National Institute for Malaria Research New Delhi (NIMR) in a timely, comprehensive, accurate, unbiased, unambiguous and transparent manner and to the National Vector-borne Disease (Malaria) Control Programme officers and the Community public who participated. Important findings will be communicated through community outreach meetings which are existing in the Health system. Results will be informed to study participants via local fieldwork supervised by District Malaria Officers. Also findings will be published in reputed journals based on Indian Council of Medical Research (ICMR) publication policy.The ICMR-NIMR ethics committee approved the study via letter No. NIMR/ECM/2023/Feb/14 dated 24 April 2023 for version 5. All standard ethical practices will be followed.
2021 年，印度在东南亚区域的疟疾负担最高，占估计疟疾病例的 79%，占与疟疾相关死亡的 83%。全球抗击艾滋病、结核病和疟疾基金支持的强化疟疾控制规划部署了关键干预措施，以减轻印度的整体疟疾负担。目前正在印度 11 个疟疾高度流行的邦评估社区消除疟疾干预措施的利用情况，并评估医疗保健系统。除了评估卫生工作者的知识、态度和实践外，还在评估消除疟疾的卫生系统准备情况、诊断试剂盒和抗疟药物的后勤和供应链管理。
该研究在 11 个疟疾流行的邦进行，这些邦的疟疾年发病率不同。共有 47 个区（疟疾控制行动的行政单位）将接受访谈和评估，涵盖 37976 户家庭。在此介绍该研究的方案，该方案是应印度卫生部和家庭福利部的要求并经其批准进行的。
本研究没有涉及患者。研究结果将及时、全面、准确、客观、明确和透明地与新德里国家疟疾研究所（NIMR）的机构伦理委员会以及国家病媒传播疾病（疟疾）控制计划官员和参与的社区公众分享。将通过现有的卫生系统社区外展会议传达重要发现。将通过由地区疟疾官员监督的当地实地工作向研究参与者通报结果。研究结果还将根据印度医学研究理事会（ICMR）的出版政策发表在知名期刊上。ICMR-NIMR 伦理委员会于 2023 年 4 月 24 日通过第 NIMR/ECM/2023/Feb/14 号信函批准了该研究，版本为 5。将遵循所有标准的伦理实践。
